As the coronavirus infections shoot up to 14.6 million worldwide, we finally have some hopeful news on vaccines! COVID-19 vaccine trials by Oxford University in the UK, by CanSino in China, BioNTech from Germany, and several others have shown positive results in their clinical trials.
More than 150 countries, India included, are in a hunt to find a vaccination at the earliest to curb the soaring infection rates.
The Oxford-AstraZeneca study which is effectively in the first spot right now has been showing promising results from the start. The preliminary data from their early trials show that the vaccine not only appears to be safe but it’s also giving a double protection with anti-bodies and killer T cells.
The others — the Chinese vaccine being developed by CanSino and studies from Germany's BioNtech which are also moving at an equal pace — have induced safe and significant immune responses.
So, with a handful of potential candidates yielding positive results, how much longer before a vaccine comes to our rescue? Tune in to The Big Story!
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)